View in EDS

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.

Saved in:
Bibliographic Details
Title: Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
Authors: Caballero-Camino FJ; Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain.; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain., Rivilla I; Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain., Herraez E; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain., Briz O; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain., Santos-Laso A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain., Izquierdo-Sanchez L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain., Lee-Law PY; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain., Rodrigues PM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain., Munoz-Garrido P; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain., Jin S; The Hormel Institute, University of Minnesota, Austin, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Peixoto E; The Hormel Institute, University of Minnesota, Austin, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Richard S; The Hormel Institute, University of Minnesota, Austin, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Gradilone SA; The Hormel Institute, University of Minnesota, Austin, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Perugorria MJ; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain., Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain., Bujanda L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain., Marin JJG; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain., Banales JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain., Cossío FP; Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain.
Source: Hepatology (Baltimore, Md.) [Hepatology] 2021 Jan; Vol. 73 (1), pp. 186-203. Date of Electronic Publication: 2020 Sep 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32145077
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Caballero-Camino+FJ%22">Caballero-Camino FJ</searchLink>; Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain.; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Rivilla+I%22">Rivilla I</searchLink>; Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Herraez+E%22">Herraez E</searchLink>; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Briz+O%22">Briz O</searchLink>; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Santos-Laso+A%22">Santos-Laso A</searchLink>; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Izquierdo-Sanchez+L%22">Izquierdo-Sanchez L</searchLink>; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lee-Law+PY%22">Lee-Law PY</searchLink>; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Rodrigues+PM%22">Rodrigues PM</searchLink>; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Munoz-Garrido+P%22">Munoz-Garrido P</searchLink>; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Jin+S%22">Jin S</searchLink>; The Hormel Institute, University of Minnesota, Austin, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Peixoto+E%22">Peixoto E</searchLink>; The Hormel Institute, University of Minnesota, Austin, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Richard+S%22">Richard S</searchLink>; The Hormel Institute, University of Minnesota, Austin, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Gradilone+SA%22">Gradilone SA</searchLink>; The Hormel Institute, University of Minnesota, Austin, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Perugorria+MJ%22">Perugorria MJ</searchLink>; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Esteller+M%22">Esteller M</searchLink>; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bujanda+L%22">Bujanda L</searchLink>; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Marin+JJG%22">Marin JJG</searchLink>; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Banales+JM%22">Banales JM</searchLink>; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.<br /><searchLink fieldCode="AU" term="%22Cossío+FP%22">Cossío FP</searchLink>; Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228302946%22">Hepatology (Baltimore, Md.)</searchLink> [Hepatology] 2021 Jan; Vol. 73 (1), pp. 186-203. <i>Date of Electronic Publication: </i>2020 Sep 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8302946 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-3350 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202709139%22">02709139 </searchLink><i>NLM ISO Abbreviation: </i>Hepatology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32145077
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hep.31216
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 186
    Titles:
      – TitleFull: Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Caballero-Camino FJ
      – PersonEntity:
          Name:
            NameFull: Rivilla I
      – PersonEntity:
          Name:
            NameFull: Herraez E
      – PersonEntity:
          Name:
            NameFull: Briz O
      – PersonEntity:
          Name:
            NameFull: Santos-Laso A
      – PersonEntity:
          Name:
            NameFull: Izquierdo-Sanchez L
      – PersonEntity:
          Name:
            NameFull: Lee-Law PY
      – PersonEntity:
          Name:
            NameFull: Rodrigues PM
      – PersonEntity:
          Name:
            NameFull: Munoz-Garrido P
      – PersonEntity:
          Name:
            NameFull: Jin S
      – PersonEntity:
          Name:
            NameFull: Peixoto E
      – PersonEntity:
          Name:
            NameFull: Richard S
      – PersonEntity:
          Name:
            NameFull: Gradilone SA
      – PersonEntity:
          Name:
            NameFull: Perugorria MJ
      – PersonEntity:
          Name:
            NameFull: Esteller M
      – PersonEntity:
          Name:
            NameFull: Bujanda L
      – PersonEntity:
          Name:
            NameFull: Marin JJG
      – PersonEntity:
          Name:
            NameFull: Banales JM
      – PersonEntity:
          Name:
            NameFull: Cossío FP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1527-3350
          Numbering:
            – Type: volume
              Value: 73
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Hepatology (Baltimore, Md.)
              Type: main
ResultId 1